학술논문

Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides
Document Type
Article
Source
In: Postgraduate Medicine. (Postgraduate Medicine, 18 August 2019, 131(6):390-396)
Subject
Language
English
ISSN
19419260
00325481